JourneyLite has been focused on surgical and non-surgical weight loss for nearly two decades, with a long-standing commitment to safety, outcomes, innovation, and patient support
Despite a small detectable increase in birth weight of newborns from GLP-1-exposed pregnancies, there was no increased risk of large or small for gestational age birth weight or cesarean delivery associated with pre-pregnancy or early pregnancy GLP-1 use, Maya and colleagues wrote
"We're passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we're doing it in a safe, affordable way that others can't deliver." Customers will need a prescription from their medical provider, based on what is "medically appropriate and necessary for each patient," the company said
Read the full blog hashtag#GLP1 hashtag#AffordableHealthcare hashtag#IndiaPharma hashtag#Semaglutide hashtag#AccessToMedicine To view or add a comment, sign in Major update in the obesity medication market: Eli Lilly and Companys Zepbound is now available via the KwikPen
All authors contributed to improving the paper and approved the final manuscript